Binge drinking is common during adolescence and can lead to the development of psychiatric disorders, including alcoholism in adulthood. Here, the role and persistent effects of histone modifications during adolescent intermittent ethanol (AIE) exposure in the development of anxiety and alcoholism in adulthood were investigated. Rats received intermittent ethanol exposure during post-natal days 28-41, and anxiety-like behaviors were measured after 1 and 24 h of the last AIE. The effects of AIE on anxiety-like and alcohol-drinking behaviors in adulthood were measured with or without treatment with the histone deacetylase (HDAC) inhibitor, trichostatin A (TSA). Amygdaloid brain regions were collected to measure HDAC activity, global and gene-specific histone H3 acetylation, expression of brain-derived neurotrophic factor (BDNF) and activity-regulated cytoskeleton-associated (Arc) protein and dendritic spine density (DSD). Adolescent rats displayed anxiety-like behaviors after 24 h, but not 1 h, of last AIE with a concomitant increase in nuclear and cytosolic amygdaloid HDAC activity and HDAC2 and HDAC4 levels leading to deficits in histone (H3-K9) acetylation in the central (CeA) and medial (MeA), but not in basolateral nucleus of amygdala (BLA). Interestingly, some of AIE-induced epigenetic changes such as, increased nuclear HDAC activity, HDAC2 expression, and decreased global histone acetylation persisted in adulthood. In addition, AIE decreased BDNF exons I and IV and Arc promoter specific histone H3 acetylation that was associated with decreased BDNF, Arc expression and DSD in the CeA and MeA during adulthood. AIE also induced anxiety-like behaviors and enhanced ethanol intake in adulthood, which was attenuated by TSA treatment via normalization of deficits in histone H3 acetylation of BDNF and Arc genes. These novel results indicate that AIE induces long-lasting effects on histone modifications and deficits in synaptic events in the amygdala, which are associated with anxiety-like and alcohol drinking behaviors in adulthood.
Introduction
Binge drinking is prevalent during adolescence (Donovan, 2004; Matthews, 2010; O'Malley et al., 1998; Wechsler et al., 2000) . Both clinical and preclinical studies have shown that alcohol use during adolescence leads to a greater risk for developing alcoholism and other psychiatric disorders in adulthood (DeWit et al., 2000; Guerri and Pascual, 2010; Grant and Dawson, 1997) . Adolescence is an important developmental period during which the brain undergoes maturation including changes in neurotransmission, gene expression, and synaptic remodeling, specifically, the formation and pruning of axons, dendrites, and synapses in various brain regions (Craiu, 2013; Fumagalli et al., 2007; Tau and Peterson, 2010; Spear, 2013) . In general, the central (CeA), medial (MeA), and basolateral (BLA) nuclei of the amygdala have been shown to be involved in the processes that regulate emotion, anxiety, and alcoholism (Koob and Volkow, 2010; LeDoux, 2000; Pandey et al., 2006; Whalen et al., 2001) . One major hypothesis of alcohol dependence involves alterations in the allostatic state driven by negative emotional adaptations within the circuitry of the amygdala that is characterized as the "dark side of addiction" (Koob, 2003 (Koob, , 2013 Koob and Volkow, 2010) .
Epigenetic processes, such as histone acetylation and DNA methylation mechanisms, have been shown to play a role in neuromaturation by contributing to the stability of gene expression during brain development (Mehler, 2008; MacDonald and Roskams, 2008; Murgatroyd and Spengler, 2011; Szyf, 2013; Witt, 2010) . Well-studied epigenetic mechanisms include histone modifications via lysine acetylation where histone deacetylases (HDACs) remove acetyl groups from histones, leading to a condensed chromatin state, blocking transcriptional activator access to DNA and thereby decreasing gene transcription (de Ruijter et al., 2003; Feng and Fan, 2009; Gräff and Tsai, 2013; Jenuwein and Allis, 2001; Thiagalingam et al., 2003) . Several genes, such as brain-derived neurotrophic factor (BDNF) and activity-regulated cytoskeleton-associated 
